FDA Grants Fast Track Designation for Sprout's Flibanserin to Treat HSDD in Postmenopausal Women

Written By Betty Pink

https://www.patientcareonline.com/view/fda-grants-fast-track-designation-for-sprout-s-flibanserin-to-treat-hsdd-in-postmenopausal-women

Betty Pink
Previous

12th Annual Luxury Luncheon, a Curated Moodboard of Hamptons Lifestyle
Next

FDA grants Priority Review to flibanserin for treating postmenopausal HSDD